IDDORVY
Live / Allowed — Third extension granted (statement of use) (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98564352
- Mark type
- Word mark
- Filed
- 22 May 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Cynthia Smuzynska
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapy, in particular, T-Cell immunotherapy; pharmaceutical preparations for the treatment of oncological and blood disorders
Owner
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
Prosecution history
- 18 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2026 — SOU EXTENSION 3 GRANTED
- 17 Aug 2026 — SOU EXTENSION 3 FILED
- 17 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 1 GRANTED
- 16 Jul 2025 — SOU EXTENSION 1 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION